KMPA in severe feud

The leadership of the Korea Pharmaceutical Manufacturers Association (KPMA) is facing a backlash as Korea’s leading pharmaceutical firms, the association’s former executive members, are still refusing to join in the new line-up.

Several large drug makers, including Dong-A Pharma and Yuhan Corp., have a plan to establish a new research-oriented group consisting of about 30 companies while ret...